2. Search Result
Search Result
Results for "

benzodiazepine derivative

" in MedChemExpress (MCE) Product Catalog:

13

Inhibitors & Agonists

1

Isotope-Labeled Compounds

1

Click Chemistry

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-W274194
    Antioxidant agent-7

    		Others Others
    Antioxidant agent-7 (SD-7) is a benzodiazepine derivative with antioxidant activity with an IC50 value of 470 nM to scavenge DPPH (2,2-diphenyl-1-picrylhydrazyl) free radical .
    Antioxidant agent-7
  • HY-103476
    Ro15-4513

    		GABA Receptor Neurological Disease
    Ro15-4513, imidazobenzodiazepinone derivative, is a partial inverse agonist of benzodiazepine receptor (BZR) . Ro15-4513 is a potent ethanol antagonist . Ro15-4513 has anti-anxiety effect . Ro15-4513 is a click chemistry reagent, it contains an Azide group and can undergo copper-catalyzed azide-alkyne cycloaddition reaction (CuAAc) with molecules containing Alkyne groups. It can also undergo strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with molecules containing DBCO or BCN groups.
    Ro15-4513
  • HY-101808
    Doxefazepam

    SAS-643

    		 GABA Receptor Neurological Disease
    Doxefazepam is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsan and skeletal muscle relaxant properties.
    Doxefazepam
  • HY-121877
    Valnoctamide
    1 Publications Verification

    Valmethamide

    		 GABA Receptor Neurological Disease
    Valnoctamide (Valmethamide), a derivative of valproate, suppresses benzodiazepine-refractory status epilepticus. Valnoctamide (Valmethamide) acts directly on GABAA receptors .
    Valnoctamide
  • HY-167650
    Fletazepam

    		Others Neurological Disease
    Fletazepam is a benzodiazepine derivative with sedative, anxiolytic and muscle relaxant effects. Fletazepam can be utilized in neurological research .
    Fletazepam
  • HY-101596
    Ethyl dirazepate

    		GABA Receptor Neurological Disease
    Ethyl dirazepate is a agent which is a benzodiazepine derivative. It has anxiolytic and possibly other characteristic benzodiazepine properties.
    Ethyl dirazepate
  • HY-U00192
    CGP11952

    		GABA Receptor Neurological Disease
    CGP11952 is a triazolyl-Benzaphenon resembling the benzodiazepines in its pharmacological action. CGP11952 is an experimental benzodiazepine derivative.
    CGP11952
  • HY-100264
    Uldazepam

    U31920

    		 GABA Receptor Neurological Disease
    Uldazepam is a benzodiazepine derivative and has the potential for anxiety syndrome treatment.
    Uldazepam
  • HY-U00215
    Ro 41-3290

    		GABA Receptor Neurological Disease
    Ro 41-3290 is the desethylated derivative of Ro 41-3696, which is a nonbenzodiazepine partial agonist at the benzodiazepine receptor.
    Ro 41-3290
  • HY-101725A
    (R)-Meclonazepam

    Ro 11-3624; Ro 11-3624/001

    		 Parasite Others
    (R)-Meclonazepam (Ro 11-3624) is an inactive enantiomer of Meclonazepam. Meclonazepam is a benzodiazepine derivative with anti-schistosomiasis activities .
    (R)-Meclonazepam
  • HY-17617
    Nastorazepide

    Z-360

    		 Cholecystokinin Receptor Endocrinology Cancer
    Nastorazepide (Z-360) is a selective, orally available, 1,5-benzodiazepine-derivative gastrin/cholecystokinin 2 (CCK-2) receptor antagonist with potential antineoplastic activity.
    Nastorazepide
  • HY-121877S
    Valnoctamide-d5

    		Isotope-Labeled Compounds GABA Receptor Neurological Disease
    Valnoctamide-d5 is the deuterium labeled Valnoctamide. Valnoctamide (Valmethamide), a derivative of valproate, suppresses benzodiazepine-refractory status epilepticus. Valnoctamide (Valmethamide) acts directly on GABAA receptors[1][2].
    Valnoctamide-d5
  • HY-129245
    Razobazam

    Hoe 175

    		 Others Neurological Disease
    Razobazam (Hoe 175) is a benzodiazepine derivative with cognitive activity. Razobazam has been shown to improve learning performance in socially deprived rats. Razobazam increased avoidance scores by 18% after training. Razobazam caused significant changes in the optical density of certain areas of the rat brain, including a 22% decrease in the lateral habenula and a 25% increase in the ventral tegmental area. Razobazam also caused a 13% increase in optical density in the prefrontal cortex of rats .
    Razobazam

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

  

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

  

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: